Cyber Threat to Healthcare and Pharma in times of Covid-19: Strategy vs. Tactical Approach
Cyber Threat to Healthcare and Pharma in times of Covid-19: Strategy vs. […]
Category: Life Sciences
Evolving cyber threats in the Covid-19 era
Evolving cyber threats in the Covid-19 era by Danilo Maruccia, Partner & […]
How to perform a robust Vaccine Technology Transfer in a challenging era
How to perform a robust Vaccine Technology Transfer in a challenging era
Operational Technology and Cyber Security must walk hand in hand
Operational Technology and Cyber Security must walk hand in hand by Danilo Maruccia […]
Impact of possible removal of the Titanium dioxide from human medicines formulations was discussed during the CMDh meeting held on 14-17 September
Impact of possible removal of the Titanium dioxide from human medicines formulations […]
5 questions you should be able to answer to ensure the security of your systems
5 questions (plus, a bonus one) you should be able to answer […]
A comparison between CSV Guideline/regulations in Japan, India and China
A comparison between CSV Guideline / regulations in Japan, India and China
EU IVDR – Clinical Evidence and Performance Evaluation
EU IVDR – Clinical Evidence and Performance Evaluation by Andrea Colombo, MD […]
Covid Vaccine Technology Transfer: 5 reasons, risks, good practices
Technology Transfer has always been a hot topic and can be even more challenging for complex processes/products like biotechnological ones.
In this Covid-19 pandemic era, different companies are facing technology transfer processes as a mandatory way to boost their covid vaccines production and follow patients’ need, shifting a series of contract manufacturers across the world that must inherit their technology and achieve compliance in a really short timing to meet the production goals.
ICSR and Pharmacovigilance Data: Challenges for Pharmaceutical companies
Pharmacovigilance Data: challenges for Pharmaceutical Companies by: Daniela Rota PV Unit Manager […]